Overview

Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
A randomized study of chemotherapy versus hormonal treatment in patients with ovarian cancer resistant or refractory to platinum and taxane.
Phase:
Phase 3
Details
Lead Sponsor:
Nordic Society for Gynaecologic Oncology
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Treatments:
Albumin-Bound Paclitaxel
Doxorubicin
Liposomal doxorubicin
Paclitaxel
Tamoxifen
Taxane